IGC Pharma (IGC) Revenue (2010 - 2025)
IGC Pharma (IGC) posted quarterly Revenue of $191000.0 for Q3 2025, down 53.64% year-over-year from $412000.0 in Q3 2024, and down 41.77% quarter-over-quarter from $328000.0 in Q2 2025.
IGC Pharma (IGC) Revenue (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Revenue for 16 consecutive years, with $191000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Revenue fell 53.64% year-over-year to $191000.0; the TTM figure through Sep 2025 stood at $1.1 million (down 6.51% YoY), while the FY2026 annual figure was $317000.0, down 75.06% from the prior year.
- Revenue eased to $191000.0 in Q3 2025 per IGC's latest filing, from $328000.0 in the prior quarter.
- Across five years, Revenue topped out at $555000.0 in Q2 2023 and bottomed at $56000.0 in Q3 2021.
- Historically, Revenue has averaged $238157.9 across 5 years, with a median of $212000.0 in 2022.
- Annual changes were most pronounced in 2021 — Revenue plunged 86.82% — and 2022, when it soared 260.71%.
- IGC Pharma's Revenue stood at $142000.0 in 2021, then soared by 133.8% to $332000.0 in 2022, then slumped by 38.55% to $204000.0 in 2023, then rose by 25.98% to $257000.0 in 2024, then dropped by 25.68% to $191000.0 in 2025.
- Business Quant data shows IGC's Revenue at $191000.0 in Q3 2025, $328000.0 in Q2 2025, and $330000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 328,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Sep 30, 2023 | 291,000.00 |
| Jun 30, 2023 | 555,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 332,000.00 |
| Sep 30, 2022 | 202,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 77,000.00 |
| Mar 31, 2021 | 81,000.00 |
| Dec 31, 2020 | 108,000.00 |